A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
Not yet recruiting · NCT07560124 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-30 | NCT07560124 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akeso | 89 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 29 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| West China Hospital of Sichuan University | Chengdu | China | 68 |